| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $2.49B | -7.8% |
| Cost of Revenue | $1.22B | -18.2% |
| Gross Profit | $1.27B | +5.1% |
| R&D Expense | $234.2M | -23.2% |
| SG&A Expense | $527.3M | -19.0% |
| Operating Income | -$36.2M | +93.2% |
| Pre-tax Income | -$115.6M | +79.1% |
| Income Tax | $3.4M | +1800.0% |
| Net Income | -$118.9M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.04B | +49.0% |
| Accounts Receivable | $101.2M | -2.3% |
| Inventory | $205.6M | -37.6% |
| Current Assets | $1.44B | +13.6% |
| Total Assets | $2.13B | -2.7% |
| Current Liabilities | $803.9M | +17.3% |
| Long-term Debt | $1.54B | -0.6% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $333.0M | +603.8% |
| Investing Cash Flow | -$5.1M | -119.0% |
| Financing Cash Flow | $1.7M | +101.8% |
| +78.5% |
| EPS (Basic) | -$0.30 | +80.1% |
| EPS (Diluted) | -$0.30 | +80.1% |
| Total Liabilities |
| $2.54B |
| -6.1% |
| Stockholders' Equity | -$413.8M | +20.3% |